Dr. Rajesh Beri brings several decades of experience in the biopharmaceutical industry specializing in process development, technology development, tech transfer, and GMP manufacturing along with strategic planning and execution. At Goodwin Biotechnology, Rajesh oversees all aspects of CDMO operations to ensure the delivery of the highest quality services and products that are in compliance with current Good Manufacturing Practices (cGMP). Prior to joining Goodwin Biotechnology, Rajesh has held leadership positions at leading biopharmaceutical companies and CDMOs in the US such as Amgen, GSK and Lonza. Rajesh has hands on as well as managerial experience from preclinical to commercial development and manufacturing of recombinant proteins, monoclonal antibodies, fusion proteins, therapeutic enzymes, polysaccharides and viral vaccines. He has contributed significantly to the approval and lifecycle management of leading biologic products such as ENBREL®, YERVOY®, ORENCIA®, OPDIVO®, ARZERRA®, BENLYSTA®, SOLIRIS® and StrenSIQ®. Rajesh earned his Masters and PhD in Chemical Engineering at Worcester Polytechnic Institute.